Jennifer Q. Zhang, MD
Assistant Professor of Surgery at the Hospital of the University of Pennsylvania
Active Surgeon, Penn Presbyterian Medical Center, Philadelphia, PA
Active Surgeon, Pennsylvania Hospital, Philadelphia, PA
Attending Surgeon, Hospital of the University of Pennsylvania, Philadelphia, PA
Department: Surgery
Contact information
Division of Endocrine and Oncologic Surgery
Hospital of the University of Pennsylvania
3400 Spruce Street, 4 Silverstein
Philadelphia, PA 19104
Hospital of the University of Pennsylvania
3400 Spruce Street, 4 Silverstein
Philadelphia, PA 19104
Education:
BS (Chemical Engineering)
Massachusetts Institute of Technology, Cambridge, MA, 2008.
MD
Johns Hopkins School of Medicine, Baltimore, MD, 2012.
Permanent linkBS (Chemical Engineering)
Massachusetts Institute of Technology, Cambridge, MA, 2008.
MD
Johns Hopkins School of Medicine, Baltimore, MD, 2012.
Selected Publications
Iwai Y, Perez-Rojas S, Thomas SM, Tadros AB, Woodward SG, Zhang JQ, Elmore LC, Freedman GM, Tchou JC, Bleznak AD, Fayanju OM: ASO Visual Abstract: Guideline-concordant surgical care for lobular versus ductal inflammatory breast cancer. Annals of Surgical Oncology July 15 2024 (Epub) Notes: doi: 10.1245/s10434-024-15691-1.Iwai Y, Perez-Rojas S, Thomas SM, Tadros AB, Woodward SG, Zhang JQ, Elmore LC, Freedman GM, Tchou JC, Bleznak AD, Fayanju OM: Guideline-concordant surgical care for lobular versus ductal inflammatory breast cancer. Annals of Surgical Oncology June 17 2024 (Epub) Notes: doi: 10.1245/s10434-024-15540-1.
Tidwell J, Maddipatla VM, Lam C, Vonderheide RV, Zhang JQ: Agonistic CD40 increases infiltration and spatial organization of cytotoxic CD8 T cells in hormone receptor positive murine breast cancer. Poster presentation at the Society of Surgical Oncology Annual Meeting, Atlanta, GA Mar. 2024.
Maddipatla V, Zhang J: CD40 Agonism activates dendritic cells and inhibits tumor growth in murine HR+ breast cancer. Oral presentation at the Academic Surgical Congress 2024, Washington, DC Feb. 2024.
Zhang J: Mechanism of agonistic CD40 therapy in murine HR+ luminal breast cancer. Oral presentation at the Early-stage Surgeon Scientist Program II Fall 2023 Symposium, NIH, Bethesda, MD Nov. 2023.
Zhang JQ, Dos Anjos CH, Sevilimedu V, Crown A, Amoroso KA, Pilewskie ML, Robson ME, Gemignani ML: Association of moderate-risk breast cancer genes with contralateral prophylactic mastectomy and bilateral disease. Annals of Surgical Oncology 30(12): 6990-6999, Nov. 2023 Notes: Epub Sept. 3, 2023.
Manik R, Grady CB, Elmore LC, Fieber JH, Freedman GM, Jankowitz RC, Tchou JC, Zhang JQ, Hubbard RA, Fayanju OM: Temporal trends and factors associated with receipt of post-mastectomy radiation after neoadjuvant chemotherapy in women with cT3 breast cancer. Annals of Surgical Oncology 30(11): 6506-6515, Oct. 2023 Notes: Epub July 17, 2023.
Pichardo MS, Zhang JQ, Fayanju OM: Will targeted axillary surgery suffice for adjuvant treatment decision-making? JAMA Surgery 158(10): 1021-1022, Oct. 1 2023 Notes: Commentary.
Rossi F, Liu M, Tieniber A, Etherington M, Hanna A, Vitiello G, Param N, Do K, Wang L, Antonescu C, Zeng S, Zhang JQ, DeMatteo RP: Myosin light-chain kinase inhibition potentiates the antitumor effects of Avapritinib in PDGFRA D842V-mutant gastrointestinal stromal tumor. Clinical Cancer Research 29(11): 2144-2157, June 1 2023.
Lanchoney O, Vonderheide RV, Zhang JQ: Agonistic CD40 demonstrates anti-tumor efficacy and synergizes with immune checkpoint blockade in hormone receptor positive breast cancer. Poster presentation at the Translational Research Cancer Centers Consortium, Seven Springs, PA Feb. 2023.